Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Milciclib in Combination With Gemcitabine in Advanced Non-Small Cell Lung Cancer

NCT05651269 is registered in ClinicalTrials.gov with Tiziana Life Sciences LTD as lead sponsor.

NCT NCT05651269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05651269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Milciclib in Combination With Gemcitabine in Advanced Non-Small Cell Lung Cancer
Lead sponsor
Tiziana Life Sciences LTD
Phase
Phase 2
Overall status
Unknown status
Start date
March 15, 2023
Completion date
June 30, 2025
Enrollment
28 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc